Insights into 3D Structure of ADAMTS13: A Stepping Stone towards Novel Therapeutic Treatment of Thrombotic Thrombocytopenic Purpura (original) (raw)
Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents murine models of thrombotic thrombocytopenic purpura
Long Zheng
Blood, 2015
View PDFchevron_right
Deficiency of ADAMTS13 causes thrombotic thrombocytopenic purpura. Editorial
HAN-MOU TSAI
Arteriosclerosis Thrombosis and Vascular Biology, 2003
View PDFchevron_right
Deficiency of ADAMTS13 Causes Thrombotic Thrombocytopenic Purpura
HAN-MOU TSAI
2010
View PDFchevron_right
Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura
Toshiyuki Miyata
Blood, 2006
View PDFchevron_right
Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura
Long Zheng
Blood, 2012
View PDFchevron_right
Role of ADAMTS13 in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura
Bernhard Lämmle
Hematology-American Society Hematology Education Program, 2012
View PDFchevron_right
Transfusion of Platelets Loaded With Recombinant ADAMTS13 (A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13) Is Efficacious for Inhibiting Arterial Thrombosis Associated With Thrombotic Thrombocytopenic Purpura
Mohammad Abdelgawwad
Arteriosclerosis, Thrombosis, and Vascular Biology
View PDFchevron_right
Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura
Bernhard Lämmle
Blood, 2004
View PDFchevron_right
Mutation of the H-bond acceptor S119 in the ADAMTS13 metalloprotease domain reduces secretion and substrate turnover in a patient with congenital thrombotic thrombocytopenic purpura
Hans Deckmyn, M. Maeyer
Blood, 2009
View PDFchevron_right
Carboxyl Terminus of ADAMTS13 Directly Inhibits Platelet Aggregation and Ultra Large von Willebrand Factor String Formation Under Flow in a Free-Thiol–Dependent Manner
Long Zheng
Arteriosclerosis, Thrombosis, and Vascular Biology, 2013
View PDFchevron_right
ADAMTS13 and von Willebrand factor interactions
Long Zheng
Current Opinion in Hematology, 2015
View PDFchevron_right
Von Willebrand Factor, ADAMTS-13, and Thrombotic Thrombocytopenic Purpura
Trung Nguyen
Seminars in Thrombosis and Hemostasis, 2010
View PDFchevron_right
The novel ADAMTS13-p.D187H mutation impairs ADAMTS13 activity and secretion and contributes to thrombotic thrombocytopenic purpura in mice
hans deckmyn
Journal of thrombosis and haemostasis : JTH, 2014
View PDFchevron_right
Degradation of Platelet-von Willebrand Factor Complexes by Plasmin: An Alternative/Backup Mechanism to ADAMTS13
Anil Chauhan
Circulation, 2014
View PDFchevron_right
The function of ADAMTS13 in thrombogenesis in vivo: insights from mutant mice
Anil Chauhan
International Journal of Hematology, 2010
View PDFchevron_right
Enzymatically Active ADAMTS13 Variants Are Not Inhibited by Anti-ADAMTS13 Autoantibodies
HAN-MOU TSAI
Journal of Biological Chemistry, 2005
View PDFchevron_right
ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura
HAN-MOU TSAI
European Journal of Pediatrics, 2006
View PDFchevron_right
ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 2. Pathogenicity in an animal model
Long Zheng
Transfusion, 2016
View PDFchevron_right
Modifying ADAMTS13 to modulate binding of pathogenic autoantibodies of patients with acquired thrombotic thrombocytopenic purpura
Andres Männik
Haematologica
View PDFchevron_right
Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura
Lawrence Rice
Journal of Thrombosis and Haemostasis, 2006
View PDFchevron_right
Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo
Long Zheng
Journal of Thrombosis and Haemostasis, 2006
View PDFchevron_right
The distal carboxyl-terminal domains of ADAMTS13 are required for regulation of in vivo thrombus formation
Anil Chauhan
Blood, 2009
View PDFchevron_right
Conformational plasticity of ADAMTS13 in hemostasis and autoimmunity
Gerry Nicolaes
Journal of Biological Chemistry, 2021
View PDFchevron_right
Generation of Anti-Murine ADAMTS13 Antibodies and Their Application in a Mouse Model for Acquired Thrombotic Thrombocytopenic Purpura
hans deckmyn
PLOS ONE, 2016
View PDFchevron_right
Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura
Valentina Bianchi
Blood, 2002
View PDFchevron_right
Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura
Bernhard Lämmle
Blood Advances, 2021
View PDFchevron_right
Thrombospondin1 and ADAMTS13 competitively bind to VWF A2 and A3 domains in vitro
YIMING ZHAO
Thrombosis Research, 2010
View PDFchevron_right
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
Ravindra Sarode
Nature, 2001
View PDFchevron_right